Fulvestrant and the sequential endocrine cascade for advanced breast cancer

Following relapse on endocrine therapy for advanced, hormone receptor-positive breast cancer, it is common for patients to experience responses to alternative endocrine agents. Fulvestrant (‘Faslodex’) is a new type of endocrine treatment – an oestrogen receptor (ER) antagonist with no agonist effects. Fulvestrant downregulates cellular levels of the ER resulting in decreased expression of the progesterone receptor. This unique mode of action means that it is important that fulvestrant is placed optimally within the sequence of endocrine therapies to ensure that patients gain maximum benefit. Fulvestrant has shown efficacy when used after progression on tamoxifen or anastrozole in postmenopausal women with advanced breast cancer. After progression on fulvestrant, subsequent endocrine treatments can produce responses in many patients, demonstrating that fulvestrant does not lead to crossresistance with other endocrine therapies. Responses to fulvestrant have also been observed in patients heavily pretreated with prior endocrine therapy. Fulvestrant is a versatile endocrine agent that may be integrated into the therapeutic sequence prior to, or subsequent to, other hormonal therapies, and represents a valuable additional antioestrogen for the treatment of postmenopausal women with advanced breast cancer

Loss of Cannabinoid Receptor CB1 Induces Preterm Birth

Preterm birth accounting approximate 10% of pregnancies in women is a tremendous social, clinical and economic burden. However, its underlying causes remain largely unknown. Emerging evidence suggests that endocannabinoid signaling via cannabinoid receptor CB1 play critical roles in multiple early pregnancy events in both animals and humans. Since our previous studies demonstrated that loss of CB1 defers the normal implantation window in mice, we surmised that CB1 deficiency would influence parturition events.Exploiting mouse models with targeted deletion of Cnr1, Cnr2 and Ptgs1 encoding CB1, CB2 and cyclooxygenase-1, respectively, we examined consequences of CB1 or CB2 silencing on the onset of parturition. We observed that genetic or pharmacological inactivation of CB1, but not CB2, induced preterm labor in mice. Radioimmunoassay analysis of circulating levels of ovarian steroid hormones revealed that premature birth resulting from CB1 inactivation is correlated with altered progesterone/estrogen ratios prior to parturition. More strikingly, the phenotypic defects of prolonged pregnancy length and parturition failure in mice missing Ptgs1 were corrected by introducing CB1 deficiency into Ptgs1 null mice. In addition, loss of CB1 resulted in aberrant secretions of corticotrophin-releasing hormone and corticosterone during late gestation. The pathophysiological significance of this altered corticotrophin-releasing hormone-driven endocrine activity in the absence of CB1 was evident from our subsequent findings that a selective corticotrophin-releasing hormone antagonist was able to restore the normal parturition timing in Cnr1 deficient mice. In contrast, wild-type females receiving excessive levels of corticosterone induced preterm birth.CB1 deficiency altering normal progesterone and estrogen levels induces preterm birth in mice. This defect is independent of prostaglandins produced by cyclooxygenase-1. Moreover, CB1 inactivation resulted in aberrant corticotrophin-releasing hormone and corticosterone activities prior to parturition, suggesting that CB1 regulates labor by interacting with the corticotrophin-releasing hormone-driven endocrine axis

Methodology of calculation of construction and hydrodynamic parameters of a foam layer apparatus for mass-transfer processes

Промислова реалізація методу стабілізації газорідинного шару дозволяє значно розширити галузь застосування пінних апаратів і відкриває нові можливості інтенсифікації технологічних процесів з одночасним створенням маловідходних технологій. У статті встановлені основні параметри, що впливають на гідродинаміку пінних апаратів, розглянуті основні конструкції та режими роботи пінних апаратів. Виявлено зв'язок гідродинамічних параметрів. Розглянуто гідродинамічні закономірності пінного шару. Вказані фактори, що впливають на процес масообміну, як в газовій, так і в рідкій фазах. Проведений аналіз ряду досліджень показав, що перспективним напрямком інтенсифікації процесу масообміну є розробка апаратів з трифазним псевдозрідженим шаром зрошуваної насадки складних форм із сітчастих матеріалів. Отже, необхідне проведення спеціальних досліджень гідродинамічних режимів роботи апарату з сітчастою насадкою і визначенням параметрів, що впливають на швидкість переходу насадки з одного режиму в інший.Industrial implementation of the stabilization method of the gas-liquid layer can significantly expand the field of use of foaming apparatus and opens up new opportunities for intensifying technological processes with the simultaneous creation of low-waste technologies. The article establishes the basic parameters influencing the hydrodynamics of foam apparatus, considers the basic constructions and operating modes of foam apparatus. The connection of hydrodynamic parameters is revealed. The hydrodynamic laws of the foam layer are considered. The indicated factors affecting the process of mass transfer, both in the gas and in the liquid phases. The conducted analysis of a number of studies showed that the perspective direction of intensification of the mass transfer process is the development of apparatuses with a three-phase fluidized bed of an irrigated nozzle of complex forms with mesh materials

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

The administration of endocrine therapy for 5 years substantially reduces recurrence rates during and after treatment in women with early-stage, estrogen-receptor (ER)-positive breast cancer. Extending such therapy beyond 5 years offers further protection but has additional side effects. Obtaining data on the absolute risk of subsequent distant recurrence if therapy stops at 5 years could help determine whether to extend treatment

Pituitary androgen receptor signalling regulates prolactin but not gonadotrophins in the male mouse

Production of the androgen testosterone is controlled by a negative feedback loop within the hypothalamic-pituitary-gonadal (HPG) axis. Stimulation of testicular Leydig cells by pituitary luteinising hormone (LH) is under the control of hypothalamic gonadotrophin releasing hormone (GnRH), while suppression of LH secretion by the pituitary is controlled by circulating testosterone. Exactly how androgens exert their feedback control of gonadotrophin secretion (and whether this is at the level of the pituitary), as well as the role of AR in other pituitary cell types remains unclear. To investigate these questions, we exploited a transgenic mouse line (Foxg1 Cre/+; AR fl/y) which lacks androgen receptor in the pituitary gland. Both circulating testosterone and gonadotrophins are unchanged in adulthood, demonstrating that AR signalling is dispensable in the male mouse pituitary for testosterone-dependent regulation of LH secretion. In contrast, Foxg1 Cre/+; AR fl/y males have a significant increase in circulating prolactin, suggesting that, rather than controlling gonadotrophins, AR-signalling in the pituitary acts to suppress aberrant prolactin production in males

Assessing parallel gene histories in viral genomes

Background: The increasing abundance of sequence data has exacerbated a long known problem: gene trees and species trees for the same terminal taxa are often incongruent. Indeed, genes within a genome have not all followed the same evolutionary path due to events such as incomplete lineage sorting, horizontal gene transfer, gene duplication and deletion, or recombination. Considering conflicts between gene trees as an obstacle, numerous methods have been developed to deal with these incongruences and to reconstruct consensus evolutionary histories of species despite the heterogeneity in the history of their genes. However, inconsistencies can also be seen as a source of information about the specific evolutionary processes that have shaped genomes. Results: The goal of the approach here proposed is to exploit this conflicting information: we have compiled eleven variables describing phylogenetic relationships and evolutionary pressures and submitted them to dimensionality reduction techniques to identify genes with similar evolutionary histories. To illustrate the applicability of the method, we have chosen two viral datasets, namely papillomaviruses and Turnip mosaic virus (TuMV) isolates, largely dissimilar in genome, evolutionary distance and biology. Our method pinpoints viral genes with common evolutionary patterns. In the case of papillomaviruses, gene clusters match well our knowledge on viral biology and life cycle, illustrating the potential of our approach. For the less known TuMV, our results trigger new hypotheses about viral evolution and gene interaction. Conclusions: The approach here presented allows turning phylogenetic inconsistencies into evolutionary information, detecting gene assemblies with similar histories, and could be a powerful tool for comparative pathogenomics.IGB was funded by the disappeared Spanish Ministry for Science and Innovation (CGL2010-16713). Work in Valencia was supported by grant BFU2012-30805 from the Spanish Ministry of Economy and Competitiveness (MINECO) to SFE. BMC is the recipient of an IDIBELL PhD fellowship.Mengual-Chuliá, B.; Bedhomme, S.; Lafforgue, G.; Elena Fito, SF.; Bravo, IG. (2016). Assessing parallel gene histories in viral genomes. BMC Evolutionary Biology. 16:1-15. https://doi.org/10.1186/s12862-016-0605-4S11516Hess J, Goldman N. Addressing inter-gene heterogeneity in maximum likelihood phylogenomic analysis: Yeasts revisited. PLoS ONE. 2011;6:e22783.Salichos L, Rokas A. Inferring ancient divergences requires genes with strong phylogenetic signals. Nature. 2013;497:327–31.Zhong B, Liu L, Yan Z, Penny D. Origin of land plants using the multispecies coalescent model. Trends Plant Sci. 2013;18:492–5.Song S, Liu L, Edwards SV, Wu S. Resolving conflict in eutherian mammal phylogeny using phylogenomics and the multispecies coalescent model. Proc Natl Acad Sci U S A. 2012;109:14942–7.Nichols R. Gene trees and species trees are not the same. Trends Ecol Evol. 2001;16:358–64.Maddison WP. Gene trees in species trees. Syst Biol. 1997;46:523–36.Suh A, Smeds L, Ellegren H. The dynamics of incomplete lineage sorting across the ancient adaptive radiation of neoavian birds. PLoS Biol. 2015;13:e1002224.McBreen K, Lockhart PJ. Reconstructing reticulate evolutionary histories of plants. Trends Plant Sci. 2006;11:398–404.Dagan T, Martin W. The tree of one percent. Genome Biol. 2006;7:118.Beiko RG, Harlow TJ, Ragan MA. Highways of gene sharing in prokaryotes. Proc Natl Acad Sci U S A. 2005;102:14332–7.Cotton JA, Page RD. Going nuclear: Gene family evolution and vertebrate phylogeny reconciled. Proc Biol Sci. 2002;269:1555–61.Kuhner MK, Yamato J. Practical performance of tree comparison metrics. Syst Biol. 2015;64:205–14.Brochier C, Bapteste E, Moreira D, Philippe H. Eubacterial phylogeny based on translational apparatus proteins. Trends Genet. 2002;18:1–5.Bapteste E, Susko E, Leigh J, MacLeod D, Charlebois RL, Doolittle WF. Do orthologous gene phylogenies really support tree-thinking? BMC Evol Biol. 2005;5:33.Leigh JW, Susko E, Baumgartner M, Roger AJ. Testing congruence in phylogenomic analysis. Syst Biol. 2008;57:104–15.Leigh JW, Schliep K, Lopez P, Bapteste E. Let them fall where they may: Congruence analysis in massive phylogenetically messy data sets. Mol Biol Evol. 2011;28:2773–85.de Vienne DM, Ollier S, Aguileta G. Phylo-mcoa: A fast and efficient method to detect outlier genes and species in phylogenomics using multiple co-inertia analysis. Mol Biol Evol. 2012;29:1587–98.Wang S, Luo X, Wei W, Zheng Y, Dou Y, Cai X. Calculation of evolutionary correlation between individual genes and full-length genome: A method useful for choosing phylogenetic markers for molecular epidemiology. PLoS ONE. 2013;8:e81106.Salichos L, Stamatakis A, Rokas A. Novel information theory-based measures for quantifying incongruence among phylogenetic trees. Mol Biol Evol. 2014;31:1261–71.Weyenberg G, Huggins PM, Schardl CL, Howe DK, Yoshida R. Kdetrees: Non-parametric estimation of phylogenetic tree distributions. Bioinformatics. 2014;30:2280–7.de Queiroz A. For consensus (sometimes). Syst Biol. 1993;42:368–72.Miyamoto MM, Fitch WM. Testing the covarion hypothesis of molecular evolution. Mol Biol Evol. 1995;12:503–13.Sanderson MJ, Purvis A, Henze C. Phylogenetic supertrees: Assembling the trees of life. Trends Ecol Evol. 1998;13:105–9.Bininda-Emonds ORP. Phylogenetic supertrees: Combining information to reveal the tree of life. Comput Biol. Dordrecht (The Netherlands): Kluwer Academic Publishers; 2004.Creevey CJ, Fitzpatrick DA, Philip GK, Kinsella RJ, O’Connell MJ, Pentony MM, et al. Does a tree-like phylogeny only exist at the tips in the prokaryotes? Proc Biol Sci. 2004;271:2551–8.Pisani D, Cotton JA, McInerney JO. Supertrees disentangle the chimerical origin of eukaryotic genomes. Mol Biol Evol. 2007;24:1752–60.Ane C, Larget B, Baum DA, Smith SD, Rokas A. Bayesian estimation of concordance among gene trees. Mol Biol Evol. 2007;24:412–26.Gordon AD. A measure of the agreement between rankings. Biometrika. 1979;66:7–15.de Vienne DM, Giraud T, Martin OC. A congruence index for testing topological similarity between trees. Bioinformatics. 2007;23:3119–24.Suchard MA, Weiss RE, Sinsheimer JS, Dorman KS, Patel M, McCabe ERB. Evolutionary similarity among genes. J Am Stat Assoc. 2003;98:653–62.Edwards SV, Liu L, Pearl DK. High-resolution species trees without concatenation. Proc Natl Acad Sci U S A. 2007;104:5936–41.Liu L, Pearl DK. Species trees from gene trees: Reconstructing bayesian posterior distributions of a species phylogeny using estimated gene tree distributions. Syst Biol. 2007;56:504–14.Liu L, Pearl DK, Brumfield RT, Edwards SV. Estimating species trees using multiple-allele DNA sequence data. Evolution. 2008;62:2080–91.Levasseur C, Lapointe FJ. War and peace in phylogenetics: A rejoinder on total evidence and consensus. Syst Biol. 2001;50:881–91.de Queiroz A, Gatesy J. The supermatrix approach to systematics. Trends Ecol Evol. 2007;22:34–41.Huson DH, Bryant D. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 2006;23:254–67.Layeghifard M, Peres-Neto PR, Makarenkov V. Inferring explicit weighted consensus networks to represent alternative evolutionary histories. BMC Evol Biol. 2013;13:274.Stockham C, Wang LS, Warnow T. Statistically based postprocessing of phylogenetic analysis by clustering. Bioinformatics. 2002;18 Suppl 1:S285–93.Bonnard C, Berry V, Lartillot N. Multipolar consensus for phylogenetic trees. Syst Biol. 2006;55:837–43.Guenoche A. Multiple consensus trees: A method to separate divergent genes. BMC Bioinformatics. 2013;14:46.Duggal R, Cuconati A, Gromeier M, Wimmer E. Genetic recombination of poliovirus in a cell-free system. Proc Natl Acad Sci U S A. 1997;94:13786–91.Reiter J, Perez-Vilaro G, Scheller N, Mina LB, Diez J, Meyerhans A. Hepatitis c virus rna recombination in cell culture. J Hepatol. 2011;55:777–83.Desbiez C, Lecoq H. Evidence for multiple intraspecific recombinants in natural populations of watermelon mosaic virus (wmv, potyvirus). Arch Virol. 2008;153:1749–54.Larsen RC, Miklas PN, Druffel KL, Wyatt SD. Nl-3 k strain is a stable and naturally occurring interspecific recombinant derived from bean common mosaic necrosis virus and bean common mosaic virus. Phytopathology. 2005;95:1037–42.Valli A, Lopez-Moya JJ, Garcia JA. Recombination and gene duplication in the evolutionary diversification of p1 proteins in the family potyviridae. J Gen Virol. 2007;88:1016–28.Gottschling M, Bravo IG, Schulz E, Bracho MA, Deaville R, Jepson PD, et al. Modular organizations of novel cetacean papillomaviruses. Mol Phylogenet Evol. 2011;59:34–42.Woolford L, Rector A, Van Ranst M, Ducki A, Bennett MD, Nicholls PK, et al. A novel virus detected in papillomas and carcinomas of the endangered western barred bandicoot (perameles bougainville) exhibits genomic features of both the papillomaviridae and polyomaviridae. J Virol. 2007;81:13280–90.Chen X, Zhang Q, He C, Zhang L, Li J, Zhang W, et al. Recombination and natural selection in hepatitis e virus genotypes. J Med Virol. 2012;84:1396–407.Cadar D, Csagola A, Kiss T, Tuboly T. Capsid protein evolution and comparative phylogeny of novel porcine parvoviruses. Mol Phylogenet Evol. 2013;66:243–53.Smith LM, McWhorter AR, Shellam GR, Redwood AJ. The genome of murine cytomegalovirus is shaped by purifying selection and extensive recombination. Virology. 2013;435:258–68.Münk C, Willemsen A, Bravo IG. An ancient history of gene duplications, fusions and losses in the evolution of apobec3 mutators in mammals. BMC Evol Biol. 2012;12:71.Daugherty MD, Malik HS. Rules of engagement: Molecular insights from host-virus arms races. Annu Rev Genet. 2012;46:677–700.Edgar RC. Muscle: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–7.Castresana J. Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol Biol Evol. 2000;17:540–52.Stamatakis A, Ludwig T, Meier H. Raxml-iii: A fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics. 2005;21:456–63.Soria-Carrasco V, Talavera G, Igea J, Castresana J. The k tree score: Quantification of differences in the relative branch length and topology of phylogenetic trees. Bioinformatics. 2007;23:2954–6.Stern A, Doron-Faigenboim A, Erez E, Martz E, Bacharach E, Pupko T. Selecton 2007: Advanced models for detecting positive and purifying selection using a bayesian inference approach. Nucleic Acids Res. 2007;35:W506–11.Doron-Faigenboim A, Pupko T. A combined empirical and mechanistic codon model. Mol Biol Evol. 2007;24:388–97.Swanson WJ, Nielsen R, Yang Q. Pervasive adaptive evolution in mammalian fertilization proteins. Mol Biol Evol. 2003;20:18–20.Shukla DD, Ward CW, Brunt AA. The potyviridae. Wallingford (UK): CABI; 1994.Chung BY, Miller WA, Atkins JF, Firth AE. An overlapping essential gene in the potyviridae. Proc Natl Acad Sci U S A. 2008;105:5897–902.Tan Z, Wada Y, Chen J, Ohshima K. Inter- and intralineage recombinants are common in natural populations of turnip mosaic virus. J Gen Virol. 2004;85:2683–96.Bravo IG, de Sanjose S, Gottschling M. The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol. 2010;18:432–8.Klingelhutz AJ, Roman A. Cellular transformation by human papillomaviruses: Lessons learned by comparing high- and low-risk viruses. Virology. 2012;424:77–98.Bravo IG, Alonso A. Mucosal human papillomaviruses encode four different e5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol. 2004;78:13613–26.Garcia-Vallve S, Alonso A, Bravo IG. Papillomaviruses: Different genes have different histories. Trends Microbiol. 2005;13:514–21.Bravo IG, Felez-Sanchez M. Papillomaviruses: Viral evolution, cancer and evolutionary medicine. Evol Med Public Health. 2015;2015:32–51.Aleman-Verdaguer ME, Goudou-Urbino C, Dubern J, Beachy RN, Fauquet C. Analysis of the sequence diversity of the p1, hc, p3, nib and cp genomic regions of several yam mosaic potyvirus isolates: Implications for the intraspecies molecular diversity of potyviruses. J Gen Virol. 1997;78(Pt 6):1253–64.Sakai J, Mori M, Morishita T, Tanaka M, Hanada K, Usugi T, et al. Complete nucleotide sequence and genome organization of sweet potato feathery mottle virus (s strain) genomic rna: The large coding region of the p1 gene. Arch Virol. 1997;142:1553–62.Tordo VM, Chachulska AM, Fakhfakh H, Le Romancer M, Robaglia C, Astier-Manifacier S. Sequence polymorphism in the 5’ntr and in the p1 coding region of potato virus y genomic rna. J Gen Virol. 1995;76(Pt 4):939–49.Verchot J, Carrington JC. Evidence that the potyvirus p1 proteinase functions in trans as an accessory factor for genome amplification. J Virol. 1995;69:3668–74.Salvador B, Saenz P, Yanguez E, Quiot JB, Quiot L, Delgadillo MO, et al. Host-specific effect of p1 exchange between two potyviruses. Mol Plant Pathol. 2008;9:147–55.Desbiez C, Lecoq H. The nucleotide sequence of watermelon mosaic virus (wmv, potyvirus) reveals interspecific recombination between two related potyviruses in the 5’ part of the genome. Arch Virol. 2004;149:1619–32.Majer E, Salvador Z, Zwart MP, Willemsen A, Elena SF, Daros JA. Relocation of the nib gene in the tobacco etch potyvirus genome. J Virol. 2014;88:4586–90.Pasin F, Simon-Mateo C, Garcia JA. The hypervariable amino-terminus of p1 protease modulates potyviral replication and host defense responses. PLoS Pathog. 2014;10:e1003985.Lopez-Lastra M, Rivas A, Barria MI. Protein synthesis in eukaryotes: The growing biological relevance of cap-independent translation initiation. Biol Res. 2005;38:121–46.Kang ST, Wang HC, Yang YT, Kou GH, Lo CF. The DNA virus white spot syndrome virus uses an internal ribosome entry site for translation of the highly expressed nonstructural protein icp35. J Virol. 2013;87:13263–78.Dolja VV, Haldeman-Cahill R, Montgomery AE, Vandenbosch KA, Carrington JC. Capsid protein determinants involved in cell-to-cell and long distance movement of tobacco etch potyvirus. Virology. 1995;206:1007–16.Carrington JC, Jensen PE, Schaad MC. Genetic evidence for an essential role for potyvirus ci protein in cell-to-cell movement. Plant J. 1998;14:393–400.Wei T, Zhang C, Hong J, Xiong R, Kasschau KD, Zhou X, et al. Formation of complexes at plasmodesmata for potyvirus intercellular movement is mediated by the viral protein p3n-pipo. PLoS Pathog. 2010;6:e1000962.Felez-Sanchez M, Trosemeier JH, Bedhomme S, Gonzalez-Bravo MI, Kamp C, Bravo IG. Cancer, warts, or asymptomatic infections: Clinical presentation matches codon usage preferences in human papillomaviruses. Genome Biol Evol. 2015;7:2117–35.Doorbar J, Gallimore PH. Identification of proteins encoded by the l1 and l2 open reading frames of human papillomavirus 1a. J Virol. 1987;61:2793–9.Hughes FJ, Romanos MA. E1 protein of human papillomavirus is a DNA helicase/atpase. Nucleic Acids Res. 1993;21:5817–23.Sarafi TR, McBride AA. Domains of the bpv-1 e1 replication protein required for origin-specific DNA binding and interaction with the e2 transactivator. Virology. 1995;211:385–96.Chen G, Stenlund A. Characterization of the DNA-binding domain of the bovine papillomavirus replication initiator e1. J Virol. 1998;72:2567–76.McBride AA. Replication and partitioning of papillomavirus genomes. Adv Virus Res. 2008;72:155–205.McBride A, Myers G. The e2 proteins: An update. In: Laboratory HPLAN. Los Alamos: Myers, G., and coworkers; 1997. p. III54–99.Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT. Papillomavirus l1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A. 1992;89:12180–4.Penrose KJ, McBride AA. Proteasome-mediated degradation of the papillomavirus e2-ta protein is regulated by phosphorylation and can modulate viral genome copy number. J Virol. 2000;74:6031–8.Poddar A, Reed SC, McPhillips MG, Spindler JE, McBride AA. The human papillomavirus type 8 e2 tethering protein targets the ribosomal DNA loci of host mitotic chromosomes. J Virol. 2009;83:640–50.Lai MC, Teh BH, Tarn WY. A human papillomavirus e2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mrna processing. J Biol Chem. 1999;274:11832–41.Zou N, Lin BY, Duan F, Lee KY, Jin G, Guan R, et al. The hinge of the human papillomavirus type 11 e2 protein contains major determinants for nuclear localization and nuclear matrix association. J Virol. 2000;74:3761–70.Steger G, Schnabel C, Schmidt HM. The hinge region of the human papillomavirus type 8 e2 protein activates the human p21(waf1/cip1) promoter via interaction with sp1. J Gen Virol. 2002;83:503–10.Hughes AL, Hughes MA. Patterns of nucleotide difference in overlapping and non-overlapping reading frames of papillomavirus genomes. Virus Res. 2005;113:81–8.Ahola H, Bergman P, Strom AC, Moreno-Lopez J, Pettersson U. Organization and expression of the transforming region from the european elk papillomavirus (eepv). Gene. 1986;50:195–205.Chen Z, Schiffman M, Herrero R, Desalle R, Burk RD. Human papillomavirus (hpv) types 101 and 103 isolated from cervicovaginal cells lack an e6 open reading frame (orf) and are related to gamma-papillomaviruses. Virology. 2007;360:447–53.Nobre RJ, Herraez-Hernandez E, Fei JW, Langbein L, Kaden S, Grone HJ, et al. E7 oncoprotein of novel human papillomavirus type 108 lacking the e6 gene induces dysplasia in organotypic keratinocyte cultures. J Virol. 2009;83:2907–16.Stevens H, Rector A, Bertelsen MF, Leifsson PS, Van Ranst M. Novel papillomavirus isolated from the oral mucosa of a polar bear does not cluster with other papillomaviruses of carnivores. Vet Microbiol. 2008;129:108–16.Stevens H, Rector A, Van Der Kroght K, Van Ranst M. Isolation and cloning of two variant papillomaviruses from domestic pigs: Sus scrofa papillomaviruses type 1 variants a and b. J Gen Virol. 2008;89:2475–81.Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 e7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934–7.Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 e6 proteins with p53. Science. 1990;248:76–9.Huibregtse JM, Scheffner M, Howley PM. A cellular protein mediates association of p53 with the e6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 1991;10:4129–35.Hartley KA, Alexander KA. Human tata binding protein inhibits human papillomavirus type 11 DNA replication by antagonizing e1-e2 protein complex formation on the viral origin of replication. J Virol. 2002;76:5014–23.Ilves I, Kadaja M, Ustav M. Two separate replication modes of the bovine papillomavirus bpv1 origin of replication that have different sensitivity to p53. Virus Res. 2003;96:75–84.Narahari J, Fisk JC, Melendy T, Roman A. Interactions of the cellular ccaat displacement protein and human papillomavirus e2 protein with the viral origin of replication can regulate DNA replication. Virology. 2006;350:302–11.Barrow-Laing L, Chen W, Roman A. Low- and high-risk human papillomavirus e7 proteins regulate p130 differently. Virology. 2010;400:233–9.White EA, Sowa ME, Tan MJ, Jeudy S, Hayes SD, Santha S, et al. Systematic identification of interactions between host cell proteins and e7 oncoproteins from diverse human papillomaviruses. Proc Natl Acad Sci U S A. 2012;109:E260–7.Nomine Y, Masson M, Charbonnier S, Zanier K, Ristriani T, Deryckere F, et al. Structural and functional analysis of e6 oncoprotein: Insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol Cell. 2006;21:665–78.Zanier K, ould M’hamed ould Sidi A, Boulade-Ladame C, Rybin V, Chappelle A, Atkinson A, et al. Solution structure analysis of the hpv16 e6 oncoprotein reveals a self-association mechanism required for e6-mediated degradation of p53. Structure. 2012;20:604–17.Briddon RW, Patil BL, Bagewadi B, Nawaz-ul-Rehman MS, Fauquet CM. Distinct evolutionary histories of the DNA-a and DNA-b components of bipartite begomoviruses. BMC Evol Biol. 2010;10:97.Chen JM, Sun YX, Chen JW, Liu S, Yu JM, Shen CJ, et al. Panorama phylogenetic diversity and distribution of type a influenza viruses based on their six internal gene sequences. J Virol. 2009;6:137

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surgery more feasible and might be more likely to eradicate micrometastatic disease than might the same chemotherapy given after surgery. We investigated the long-term benefits and risks of NACT and the influence of tumour characteristics on outcome with a collaborative meta-analysis of individual patient data from relevant randomised trials. Methods We obtained information about prerandomisation tumour characteristics, clinical tumour response, surgery, recurrence, and mortality for 4756 women in ten randomised trials in early breast cancer that began before 2005 and compared NACT with the same chemotherapy given postoperatively. Primary outcomes were tumour response, extent of local therapy, local and distant recurrence, breast cancer death, and overall mortality. Analyses by intention-to-treat used standard regression (for response and frequency of breast-conserving therapy) and log-rank methods (for recurrence and mortality). Findings Patients entered the trials from 1983 to 2002 and median follow-up was 9 years (IQR 5–14), with the last follow-up in 2013. Most chemotherapy was anthracycline based (3838 [81%] of 4756 women). More than two thirds (1349 [69%] of 1947) of women allocated NACT had a complete or partial clinical response. Patients allocated NACT had an increased frequency of breast-conserving therapy (1504 [65%] of 2320 treated with NACT vs 1135 [49%] of 2318 treated with adjuvant chemotherapy). NACT was associated with more frequent local recurrence than was adjuvant chemotherapy: the 15 year local recurrence was 21·4% for NACT versus 15·9% for adjuvant chemotherapy (5·5% increase [95% CI 2·4–8·6]; rate ratio 1·37 [95% CI 1·17–1·61]; p=0·0001). No significant difference between NACT and adjuvant chemotherapy was noted for distant recurrence (15 year risk 38·2% for NACT vs 38·0% for adjuvant chemotherapy; rate ratio 1·02 [95% CI 0·92–1·14]; p=0·66), breast cancer mortality (34·4% vs 33·7%; 1·06 [0·95–1·18]; p=0·31), or death from any cause (40·9% vs 41·2%; 1·04 [0·94–1·15]; p=0·45). Interpretation Tumours downsized by NACT might have higher local recurrence after breast-conserving therapy than might tumours of the same dimensions in women who have not received NACT. Strategies to mitigate the increased local recurrence after breast-conserving therapy in tumours downsized by NACT should be considered—eg, careful tumour localisation, detailed pathological assessment, and appropriate radiotherapy